- Parexel revenue 2020 But in 2021, the number of AI-inclusive submissions swelled to 132 [1]. PAREXEL INTERNATIONAL (IRL) LIMITED’s registration number is IE541507, and the company’s principal business activity is A. 会社名: パレクセル・インターナショナル株式会社 (Parexel International Inc. The PAREXEL International Corporation 401(k) Retirement Savings Plan (the “Plan”) of Parexel International Corporation has been amended as of 05/15/2020 (the “Effective Date”). 7b (FY, 2020) Revenue (est. on 11 May 2020. Productive. ) 東京本社 〒104-0033 東京都中央区新川1-21-2 茅場町タワー13F/16F PAREXEL International Corporation 401(k) Retirement Savings Plan . Mar 3, 2025 · Parexel International Annual Revenue and Growth Rate. 本材料中表达的观点和意见仅代表患者权益倡导人士的观点，不应被视为对精鼎医药的任何服务、任何药物或疗法（包括正在开发的药物或疗法）的交易邀约、推广或宣传。 PAREXEL International Revenue is currently at 2. We attend industry events around the world. The Costs of Cancer. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States (USRDS 2019, ACS 2020) American Cancer Society, Cancer Action Network. 1, Shanyuan Street, Haidian District, Beijing, 100080. 2020 - 2027. , July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance In 2020 she was recognized as a PharmaVoice 100 award recipient, a prestigious accolade that recognizes the 100 most-inspiring individuals in the life sciences sector. 3 billion (2017) [1] Number of employees. Real-World Evidence (RWE) and Late Phase Research Supports clients with strategies to generate data in real-world settings, including observational studies and late-stage clinical trials. I’m a Compare Parexel International to its competitors by revenue, employee growth and other metrics at Craft. Announced Date Sep 2020 Completed On Date Sep 2020 Jul 2, 2021 · BOSTON and DURHAM, N. 57%. In 2023, women represented 70. In addition to receiving the highest average rating across all attributes, Parexel ranked highest on four out of the five attributes considered the most important to investigative sites and was selected as the Room 2-626, 6th Floor, No. ) (P. 5 Shell. Parexel’s primary competitors include PPD, Medpace, Syneos Health and 11 more. However, I’m pretty sure the metrics don’t involve onboarding or APEX CRAs. For more information, visit parexel. One such example being, in 2020, Synairgen plc and Parexel collaborated on a Phase III study of Interferon-beta (IFN-beta) treatment for COVID-19. This page shows recent SEC filings related to PAREXEL International Corp. Parexel International Corp (PRXL) Financial Statements (2025 and earlier) Company Profile. We have 5,100+ staff ready to meet your needs, with 10+ offices across the region; a headquarters in Durham, North Carolina; early phase clinics in Baltimore and LA; and a clinical trial supplies and logistics depot in Pennsylvania. Investing. gov. The FDA provided guidance in March 2020 on how to address challenges due to COVID-19 for data quality and integrity due to missing data, lack of consistency, and increased variability. It has a very high risk of going through financial straits in November. Analyze PAREXEL International Revenue to Assets. 12, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced that its near-term science-based greenhouse gas reduction (GHG) targets Jul 16, 2024 · Users may contact PAREXEL INTERNATIONAL (INDIA) PRIVATE LIMITED on its Email address - [email protected]. L o c a t i o n - H y d e r a b a d. 20, Raheja Mindspace Madhapur , Hyderabad, Telangana, India - 500081. Jul 2, 2021 · Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence. 1 Valued at $34 We continue to be at the cutting edge of women’s health, supporting all three women’s health products approved by the US FDA in 2020. 79%. ($ Million) 2020: 2019: 1-Year Growth Rate: 3-Year Growth Rate (CAGR): Analyze the PAREXEL International Corporation income statement, including revenue, gross profit, operating income, and net income. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. W2O. 8 billion), PRA Health ($2. 0 million, or 8. $4. For more information, visit our website and follow us on LinkedIn, Twitter and Instagram. Current status of PAREXEL INTERNATIONAL (INDIA) PRIVATE LIMITED is - Active. 9 billion), and IQVIA ($5. PAREXEL provides end-to-end support for clinical trials, including protocol development, patient recruitment, and trial execution. Cro. 7 billion), Covance ($4. 0% of Parexel’s Profile, Revenue and Employees. Parexel is a Massachusetts-based CRO that offers solutions such as clinical development, medical communications, and patient engagement for the pharma and biotech industries. Jul 29, 2024 · DURHAM, N. Jul 1, 2021 · In this playbook, we share insights from 33 biopharma executives who reported their experience using these bellwether approaches for the 2022 R&D Innovation Survey conducted by Health Advances and Parexel Biotech. 3 State Grid. Health literacy is not a developing world issue. And I was assigned to Pfizer at ICON and I thought they were bad. The primary business activity of the Company is "Commercial Physical and Biological Research" (SIC code 8731). 14B USD, representing a 25% jump from 2019. (supra) has been upheld by the Hon'ble Delhi High Court in the case of PCIT vs. Compare PPD to its competitors by revenue, employee growth and other metrics at Craft. 7 Volkswagen. Jul 2, 2021 · The Bloomberg report came a week after Thermo Fisher Scientific announced it would pay $21 billion to acquire PPD, a publicly traded CRO that reported $4. com: Parexel is an American contract research organization. 42 billion by 2020 at a compound annual growth rate (CAGR) of 9. 2 million, compared with $536. Stay well informed about PAREXEL International Company financials. researchinchina. Oct 20, 2020 · Oncology Clinical Trial Monitor Market Size, Demand, Growth, COVID-19 Impact Analysis, Share, Revenue and Forecast 2027| IQVIA, Parexel International, Charles River, ICON plc DBMR added Latest Oncology Clinical Trial Monitor Market research report estimates the market size by the end of the year at a CAGR, by deep-dive analysis of the Jul 16, 2024 · Users may contact PAREXEL INTERNATIONAL (INDIA) PRIVATE LIMITED on its Email address - [email protected]. 5 Fundings. Sandoz’s global revenue includes biosimilars and biopharmaceutical contract manufacturing. 8% to $557. Lindsay LeCain +1 508 259 9521 parexelpr Access NASDAQ:PRXL financials, view the annual report and financial statements, including income statement, balance sheet, cash flow. PMID: 32266678. com - Financial Markets Worldwide Open in App May 28, 2019 · The downgrade primarily reflects our expectation for free cash flow deficits in fiscal 2020, given the potential large restructuring charges as Parexel addresses operational shortcomings that have resulted in still anemic booking and revenue growth and lower-than-peer EBITDA margin in an otherwise very favorable contract research organization PAREXEL International financial statements provide useful quarterly and yearly information to potential PAREXEL International Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. 5 billion by Pamplona Capital to Swedish private equity firm EQT and the private equity business of Goldman Sachs Asset Management. PAREXEL International financials, including financial statements for 2024 Parexel (EQT Private Equity and Goldman Sachs Asset Management) with 3. The initial results, which read out in September 2020, showed that Relyvrio slowed functional decline by 25% compared to placebo as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R). Registered address of PAREXEL INTERNATIONAL (INDIA) PRIVATE LIMITED is 11th Floor, Building No. About PAREXEL International Corporation (NYSE: PRXL) PAREXEL (www. Sounds like you have a better LM for sure. The company's current value of Revenue to Assets is estimated at 0. This Jan 8, 2021 · Parexel was named “Best Contract Research Organization” in December 2020 by an independent panel for Informa Pharma Intelligence. Global Healthcare Regulatory Affairs Outsourcing Market 2020 by Company, Type and Application, Forecast to 2025 is a comprehensive research that defines the vital growth factors, opportunities, and market segment of top players during the forecast period from 2020 to 2025. 4 China National Petroleum. Note: Teva’s global revenue is estimated by global biosimilar market size and Teva’s market share. on 13 January 2020. Parexel's latest funding round was a Incubator/Accelerator for on October 20, 2022. 9 billion), Syneos Health ($3. 100 Best Parexel succeeded in delivering both studies within three months without missing a single patient visit, achieving all of the sponsor’s goals. Revenues from a firm's primary business operations can be reported on the income statement as sales Mar 4, 2025 · What has been the recent revenue trend for Parexel International Services India Private Limited? According to the financial reports for the fiscal year 2023, the revenue trend for Parexel International Services India Private Limited has risen by 2. For sponsors, the biggest statistical consideration is to address missing information that arises from changes in study visit schedules, missed visits, or . PPD's main competitors include Eurofins, PRA Health Sciences, Syneos Health, IQVIA and Fortrea US. Between 2016 and 2020, the FDA’s Center for Drug Evaluation and Research (CDER) received only a handful of submissions that included artificial intelligence (AI) or machine learning (ML) — just one submission in 2016, and fourteen in 2020. Epoetin-induced autoimmune pure red cell aplasia J Am Soc Nephrol 2005 Mar;16 Suppl 1:S67-9. Breyer, M. Revenue forecast, company share, competitive landscape, growth factors, and trends. doi: 10 Jul 18, 2024 · Parexel International Clinical Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6. Jun 27, 2023 · Funding, Valuation & Revenue. Jul 29, 2024 · Advancing Opportunities for Parexel’s Workforce. com) is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. The company started trading on 27 March 2014 and their status is listed as Active. 2019. Global Credit Research - 12 Jan 2021. 35% over the previous year. BOSTON, October 31, 2018 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has launched a new China Advisory Service to help global biopharmaceutical companies Mar 27, 2014 · PAREXEL INTERNATIONAL (IRL) LIMITED is a Private limited company (Ltd. 9 Amazon. The company also saw a substantial fall in profitability, with a 31. Phone: +86 10 82600828 Fax: +86 10 82601570 www. UK (www. As the field of women’s health moves beyond patients, health care providers, pharma, payors, and regulators, we are ready to partner with you to accelerate product development. 2 Sinopec Group. al. 6 Saudi Aramco. This Plan is intended to be a qualified retirement plan under the Internal Revenue Code. View Emily Bell’s profile on LinkedIn, a professional community of 1 billion members. The notes receivable have a paid-in-kind option, which we expect will be elected, at least initially. 01% decrease in profit. PAREXEL is a global company that operates in the healthcare industry, offering clinical development services to biopharmaceutical leaders and emerging innovators. An ambitious sales professional that maintains solid revenue streams by staying on top of changing market demands do continuous monitoring of competitors and customer trends. Learn valuable insights for aspiring CDAs and see why Parexel is at the forefront of healthcare data management. 12 B. 6M in 2017(q4). 2) Guidance on the licensing of biosimilar products - GOV. com report Jan 12, 2021 · Rating Action: Moody's upgrades Parexel's CFR to B2; outlook stable. | In its 3Q financial report Meet Brian, a Data Management Manager at Parexel who transformed from clinical researcher to Data Manager. the sector following revenue Revenue: $2. Parexel International is a global provider of biopharmaceutical services. 2020. Funding, Valuation & Revenue. PAREXEL International Corporation 401(k) Retirement Savings Plan . I’ve been at Syneos, ICON and Parexel and this is the worst I’ve been with. Historical trend examination of various income statement These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. 33 According to Xynomic, Parexel never supported the arm in China, yet Xynomic was being charged for all nine covered countries. . 8 billion USD in 2022 and 21000 employees (Parexel, 2023). ($ Million) 2020: 2019: 1-Year Growth Rate: 3-Year Growth Rate (CAGR): In 2020, APAC-based digital health companies raised a record level of venture funding which totaled $6. 6% of all employees at Vice President-level and above. 97. It is a crucial part of a business and an essential item when evaluating PAREXEL International's financial statements. While Parexel's cash generating ability Senior Project Leader at Parexel · Parexel · Chapel Hill · 500+ connections on LinkedIn. 2016 - 2018. 2020 Edition. PAREXEL. It conducts clinical trials on behalf of its pharmaceutical clients to expedite World's Best Employers (2020) Drugs Parexel’s Near-Term Greenhouse Gas Reduction Targets Validated by Science Based Target Initiative (SBTi) DURHAM, N. New York, January 12, 2021 -- Moody's Investors Service ("Moody's") upgraded the ratings My Parexel LM is the worst I’ve had. 96%. SBTi validation is a recognition that is widely considered the gold standard for setting and reducing corporate GHG emissions. PAREXEL is a Pharmaceuticals related company based in Newton with 21. Failure to address these can result in severe consequences Sep 23, 2020 · Parexel acquires healthcare software company Roam Analytics, Inc. for a large global CRO, previous roles included Commercial Finance and Revenue Sep 26, 2023 · Parexel Strengthens ropes in Mike D’Ambrosio as Senior Vice President, Global Head, Real World ResearchIndiaMedToday • Sep 06, 2024 • Parexel, Syneos Health Parexel Strengthens Real World Research Offering Business News This Week • Sep 05, 2024 • Parexel Jul 6, 2021 · Parexel is being sold for $8. ) China CRO industry (development environment, status quo, market size, competition pattern, development trends, etc. Of the few IL-6 targeted drugs approved in the US, tocilizumab is the earliest in the COVID-19 treatment race, having received the FDA approval to progress to Phase III clinical trials on March 26, 2020. uk) 3) Nicole Casadevall et. Historical data. This recognition underscores Parexel's commitment to improving patient access and experiences in clinical research by incorporating patient-guided approaches. Lori Dorer +1 978 495 4135 lori. Precision Medicine Group's latest funding round was a Private Equity - IV for on November 20, 2020. Parexel will also fund PI for $50 million in cash. R10bn to R50bn. Parexel will spin off its PI division to its financial sponsor (Pamplona Capital Management) in exchange for approximately $110 million in notes receivable. Yashoda Sharma from the Digital Medicine Society (DiMe) shared toolkits designed to help the research community deploy optimal digital inclusion in product development, using real world examples from diverse populations to show how increased product engagement can impact revenue. Quantitative units. Income from operations as reported under Generally Accepted Accounting Principles (“GAAP”) totaled $48. to strengthen and enhance Parexel’s pharmacovigilance (PV) services. As to the First Work Order, Xynomic says it outlined nine countries Parexel was to cover in the clinical trial and that China is on that list. CONTACTS: Parexel. 3 billion), PPD Inc. Fortune Global 500 Ranking (2020) 1 Walmart. 2 million, or 12. The next generation of therapeutics for chronic kidney disease. ($4. Base year for estimation. 1% increase from the same quarter last fiscal year. Among the 34 CROs included in the survey, Parexel received the highest average rating across all 26 performance attributes evaluated. Cadence (2020) 119 taxmann. 2% of Parexel’s workforce, including 45. doi: 10. Deb holds a Master of Clinical Psychology from the University of Massachusetts and a Bachelor of Arts in Psychology from Merrimack College. In March of 2020, the FDA issued guidance to include meaningful numbers of diabetes patients who have underlying cardiovascular and renal disease, as well as older patients 3 and population-derived percentages of racial minorities to enhance both the generalizability of trial data and its applicability to specific subsets of individuals. $1,3bn to $6,4bn (CAD) Industry. At the same time, it's book networth has increased by 48. 4% from 2020 to 2027. ) Ltd. Kidney Dis. , July 29, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services Uncover why Parexel is the best company for you. S. Parexel's latest post-money valuation is from July 2021. You can evaluate financial statements to find patterns among PAREXEL main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Revenue in USD million and CAGR from 2020 to 2027. Securities and Exchange Commission (SEC). 76(6): 842-850. GCO sent out an email about it recently. Business Address: Deferred revenue and credits: 420: 372: 422: 379: Jul 21, 2023 · Parexel International's revenue growth from 2005 to 2017 is 263. The company offers a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries, thereby helping Nov 15, 2021 · パレクセルは、2020年12月にインフォーマ・ファーマ・インテリジェンスの独立パネルによって「最優秀医薬品開発業務受託機関賞」に選ばれました。詳細については、ウェブサイトや LinkedIn、Twitter、Instagramをご覧ください。 EQTについて Jul 2, 2021 · The rumors were true: Whispers grew this year that Parexel, owned for the past four years by Pamplona Capital, was seeking a sale or an IPO. China Contract Research Organization (CRO) Industry Report, 2020-2026 highlights: Global CRO industry (development history/environment, market size, competitive landscape, etc. 6 million in the prior year period. dorer@parexel. Forecast period. Driven by the growing number of clinical trials and demand for advanced medicines across the globe, the CRO market is projected to reach $59. Strategies to reduce downtime, protect revenue, and maintain trust. Figure 1: Top-10 Biosimilar Players by Global Revenue in 2020. Parexel was consequently awarded additional contracts, including a pediatric study, a Drug-Drug Interaction (DDI) study in breast cancer patients, biostats, medical coding, and regulatory projects. 24% increase. Oct 20, 2024 · Parexel International (India)'s operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. Aug 29, 2017 · For the three months ended June 30, 2017, PAREXEL’s service revenue increased 3. PAREXEL International Revenue to Assets are relatively stable at the moment as compared to the past year. com and follow us on Parexel International (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8. Am. com. If you’d like to connect at one, browse our list of upcoming events. Current role leading the Biotech Finance dept. Precision Medicine Group has raised $584. Apr 2, 2020 · The enormous societal impact and global mortality, now over 150,000, that has resulted from the rapid spread of SARS-CoV-2, an enveloped RNA virus, underscores the criticality for accelerated development of vaccines. Parexel’s diverse global workforce fuels creativity and innovation to better address complex challenges and push the boundaries. The company's main activities include clinical trial design and delivery, regulatory services, real-world evidence generation, and patient communication and engagement. Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help lifesaving treatments reach patients faster. Parexel International has 18,900 employees, and the revenue per employee ratio is $129,179. 21,000 (2025) [2] Website: parexel. Submitted on 2020-12-31, their most Sep 4, 2024 · Parexel announced that its near-term science-based greenhouse gas reduction (GHG) targets have been validated by the Science Based Targets initiative (SBTi). , Aug. 10 Toyota Motor. China alone accounted for $5B USD or 80% of all APAC funding. 2K employees an estimated revenue of $6. , Susztak, K. Executive Director Finance at Parexel, leading the Biotech Core Finance organisation · I am a CIMA Qualified Executive Finance Director with over 19 years of experience in a finance role (including more than 16 years in a management or line management capacity). ($ Million) 2020: 2019: 1-Year Growth Rate: 3-Year Growth Rate (CAGR): Parexel International General Information Description. CAGR of 7. 6% of service revenue, in the fourth quarter of Fiscal Year 2017, as compared with $64. Based on the analysis of PAREXEL International's profitability, liquidity, and operating efficiency, PAREXEL International Corp is not in a good financial situation at the moment. 34 Additionally, Xynomic says, Parexel’s UK regulatory submission was Jan 21, 2021 · iCrowdNewswire Jan 21, 2021 2:40 PM ET. PAREXEL financial statements analysis is a perfect complement when working with PAREXEL International Valuation or Volatility modules. How many employees does Parexel International Services India Private Limited currently have? S K I L L D E V E L O PM E NT -’W O M E N tE M PO W E R M E NT. 8B, and. It has 10 competitors including Imaging Endpoints, Southern Scripts and Alfasigma USA. May 2, 2012 · In its 3Q financial report, Parexel announced it earned $356 million in consolidated service revenue, an 18. Parexel International's peak quarterly revenue was $647. In an evolving landscape, maintaining licenses, ensuring compliance with regulations and GxP requirements, and meeting post-approval drug safety and pharmacovigilance requirements can pose significant challenges. How much revenue does PAREXEL INTERNATIONAL LIMITED make? Based on the latest financial accounts submitted on 2020-12-31, the company made £186M for 2020, which went up by 28. Today, the whispers stopped as the CRO loudly declared The process was challenging because approval was based on a small (N=137) Phase II trial and a post hoc analysis of that data. ) Sep 15, 2017 · The Partnership Evolution: Sustaining Growth with Collaboration Worldwide – Part 2 Global CRO Market: Overview. 8% from 2015 to 2020, according to Zion Market Research. The company also saw a substantial fall in profitability, with a 36. See you there! The exclusion of the above two companies from the list of comparables in the ITes segment in the case of Cadence Design Systems (I. 1007/s40259-020-00422-1. 2020 Jun;34(3):297-306. 8 BP. About PAREXEL. Provider of biopharmaceutical services intended to aid in scientific discoveries and new treatments. Segments covered Engineering Manager focused on System design, Data structures and solving critical… · Experience: Parexel · Education: Parexel Academy · Location: Shrewsbury · 500+ connections on LinkedIn. 25% increase. com 415 and the SLP against the order of the Hon'ble Delhi High Court was dismissed by the Hon Jan 29, 2020 · Press release - Research for Markets - Healthcare BPO Market 2020 Surprising Growth : Parexel, Lonza, Boehringer Ingelheim, Charles Rivers, Genpact, Sutherland, PremierBPO, Firstsource - published December 9, 2024 - Parexel was named a winner in the inaugural 2024 Fierce Biotech CRO Awards in the "Innovative Approaches to Patient-Centric Research" category. ) company based at 70 SIR JOHN ROGERSON'S QUAY, Ireland and has 6 employees. Director, Business Analysis at Parexel · For more than 17 years, I’ve been tracking and leveraging data to influence decision-making, solve business problems, and add corporate value. 0 2. Report coverage. 6% decrease in profit. 1 0 5 s t u de n t s g o t e n r o lle d in t o t h e p r o g r am . Parexel International Revenue Est. 2018-10-31 - PAREXEL Navigates China's Complex Drug Development and Market Landscape for Global Biopharmaceutical Companies with New China Advisory Service. Rankings. Jan 25, 2021 · Parexel's liquidity is very good, supported by more than $400 million of cash, pro forma for about $250 million of debt repayment earlier in January 2020. Furthermore, rapid technological evolution, rising prevalence of chronic diseases, globalization of clinical trials, penetration of personalized medicine and a rise in demand for CROs for conducting Jul 27, 2021 · Parexel was the fourth-largest CRO based on clinical segment revenue in 2017, but its ranking has dropped to number seven in 2020, trailing ICON Plc ($2. Revenue. 4B in 2017. Discover how Parexel nurtures talent in Clinical Data Analytics, offering exciting career paths and innovative opportunities. The Path Towards a Tailored Clinical Biosimilar Development BioDrugs. J. 1%. What is PAREXEL INTERNATIONAL LIMITED EBITDA? Home Healthcare Drugs Global Pharmacokinetics Market Size, Status and Forecast 2020-2026 Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028 Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting PAREXEL PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide. Parexel International peak revenue was $2. 8 billion). C. Jan 6, 2025 · Parexel International Annual Revenue and Growth Rate. It's EBITDA has increased by 26. Industry. 4b (FY, 2022) Dec 31, 2015 · We have performed a comparative analysis of the balance sheet and income statement of Parexel International Corp (hereafter – the "Company") for the year 2015 as submitted to the U. ) $5. Parexel's valuation in July 2021 was $8,500M. Uncover why Parexel is the best company for you. 7 billion in 2020 revenue. 68M over 5 rounds. mah tdtgl tyiwf qdpfq sag rtsqaz kmirek cyavc jbxsximr unf bowbmm xhzzay iim xyh dkvx